Skip to content
‹ Back to IndustriesSciences

Trends in Pet and Animal Wellbeing

The article discusses the integration of nutrition, supplements, and wellness trends from human health into pet and animal health. It highlights the importance of maintaining pets' health through a combination of a high-quality diet, regular exercise, and veterinary care. Experts from ADM Nutrition emphasize the growing role of supplements in supporting pet microbiome and overall well-being.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Michelle Dawn Mooney · · Animal SupplementsAnimal WellbeingMicrobiomePet Health
Share
Trends in Pet and Animal Wellbeing

Key takeaways

01

A pet's health and wellness depend on a quality diet, regular exercise, routine veterinary care, and appropriate supplements.

02

Supplements such as prebiotics, probiotics, and postbiotics support a healthy microbiome in pets, which is crucial for their overall health.

03

Consumers should research pet supplements to ensure they are beneficial and effective.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Nutrition, supplements, and wellness are the foundation for a healthy human life. And that trend is now leaking into our pets and animal health. According to a recent Pet Age report, “a pet’s health and wellness is a three-dimensional sphere that includes several interdependent parts including a high-quality diet, regular exercise, routine veterinary care, a loving home, and supplements to support health.”

Caitlin Donohue, Director of Business Development Microbiome Solutions, Pet & Animal Wellbeing, ADM Nutrition, pointed out, “it’s a lot cheaper to prevent problems than to treat them.” She and her colleague, Bill Bae, Business Development Director, Market Ready Solutions – NA&LATAM, Pet and Animal Wellbeing, ADM Nutrition, sat down with host Michelle Dawn Mooney to discuss supplement care for pets. Bae continued, “having those supplements… is really beneficial for your pets in general.”

Consumers should expect to see more supplements for their pets’ microbiome. The term microbiome describes a community of different organisms. The gut microbiome and oral microbiome are the most studied. Each community is a competition between desirable bacteria and undesirable bacteria. A healthy microbiome is usually reflective of overall good health.

Supporting supplemental ingredients include pre-, pro-, and post-biotics. “The prebiotic is the food that the probiotics need,” explained Bae. A newer term, postbioitics, are organisms that are no longer living. “Each provides a health benefit. Post is derived from the probiotic, and ultimately promoting a more diverse, beneficial microbiome for the host, be it a dog, cat, or human,” explained Donohue.

Enzyme-focused supplements help facilitate proper digestion. “Enzymes are another way to support a breakdown of other various diets for cats and dogs,” said Donohue. These can help balance pet diets and support overall well-being. “Systemic enzymes support bodily functions within the tissues, organs, blood flow, things like that,” said Donohue.

Bae warns that consumers should do their research when buying pet supplements. Carefully look at what is going into your pet’s gut flora. Bae says there are “macro terms that cover a lot of things.” Delivering supplements is possible in various forms, from single-serve packs, chews, broths, pastes, or gels.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

MD

Michelle Dawn Mooney is a media professional and host known for her work in broadcast journalism and B2B content.

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Why shared auto-injectors keep forcing rebuilt device files

Why shared auto-injectors keep forcing rebuilt device files

Vertex Knight co-founder Fubin Wu names digitalization, personalization and large-volume delivery as the trends reshaping drug delivery devices, arguing structured data can end rebuilding design files for shared auto-injectors. ISPE says no regulatory pathway exists for platform devices, and ONdrugDelivery counts 182 large-volume subcutaneous biologics, about 15% of the injectable pipeline.

  • 01A device shared across drug products still triggers repeated design control work for each new combination product, and ISPE's November 2025 article says no regulatory pathway yet exists to approve a platform device.
  • 02FDA's May 2024 draft platform technology designation under section 506K is written for drug product applications, so device design files sit outside it.
  • 03Large-volume subcutaneous biologics above 2 mL numbered 182 in a January 2025 ONdrugDelivery review, about 15% of IV and SC agents; Advanced Drug Delivery Reviews reported in July 2026 that volumes up to 25 mL are now pursued.

Oct 22, 2026

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's Pingshan prefilled syringe plant in Shenzhen won the Innovation (Novel Technology) category at ISPE's 2026 Facility of the Year Awards. In the transcript ISPE posted with its podcast, CaiXue Wei describes vertical design, AGV-assisted transfer, AI inspection and 5G-MEC as one integrated system built around a 330 million-syringe annual capacity; Hepalink's own release adds a 24-meter warehouse, sub-10 millisecond 5G and 24,000-unit-an-hour inspection.

  • 01Hepalink's 24-meter automated warehouse raised space utilization 52 percent over a traditional layout on a land-scarce Shenzhen site supporting 330 million syringes a year.
  • 02AGVs pass material through vaporized hydrogen peroxide chambers straight into Grade A isolators, and Hepalink credits the zero-touch flow for a 100 percent first media fill.

Oct 22, 2026

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers University of Technology's AI scientist Eve analyzed about 60,000 public yeast records, came up with almost 2,000 testable ideas, and took full charge of planning the experiments and telling other robots what to do, according to CORDIS. Humans handled safety checks and plate moving.

  • 01The key step for company labs is translation: turning hypotheses into machine-executable protocols and getting contextualized results back to the reasoning layer fast.

Oct 19, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

MD
Michelle Dawn Mooney

Michelle Dawn Mooney is a media professional and host known for her work in broadcast journalism and B2B content.

CD
Caitlin Donohue

Director of Business Development Microbiome Solutions, Pet & Animal Wellbeing

ADM Nutrition

Caitlin Donohue focuses on microbiome solutions and animal well-being in her role at ADM Nutrition.

BB
Bill Bae

Business Development Director, Market Ready Solutions – NA&LATAM, Pet and Animal Wellbeing

ADM Nutrition

Bill Bae specializes in market solutions for pet and animal well-being at ADM Nutrition.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512